LAS VEGAS, NEVADA–(Sept. 29, 2016) – Cell MedX Corp. (OTCQB:CMXC), (“Cell MedX” or the “Company”) a development stage company focused on the commercialization of therapeutic devices for patients living with diseases such as diabetes, is pleased to announce that on…
LAS VEGAS, NV–Cell MedX Corp. (OTCQB: CMXC), (“Cell MedX” or the “Company”), a development stage company focused on the commercialization of therapeutic devices for patients living with diseases such as diabetes, is pleased to provide its shareholders with an update…
LAS VEGAS, NV–Cell MedX Corp. (OTCQB: CMXC), (“Cell MedX” or the “Company”) is pleased to announce that it has engaged Nutrasource Diagnostics Inc. (“NDI”) to commence clinical trials of its innovative and proprietary technology branded under the trade name eBalance. The…
LAS VEGAS, NV–Cell MedX Corp. (OTCQB: CMXC) (“Cell MedX” or the “Company”), announces that on March 3, 2016 it has entered into a loan agreement (the “Loan Agreement”) for a loan in the principal amount of $50,000 (the “Loan”). The…
Website to Offer Ongoing Experiences and Research From Growing Cohort of Users LAS VEGAS, NV–Cell MedX Corp. (OTCQB: CMXC) (“Cell MedX” or the “Company”), a development stage company focused on the commercialization of therapeutic devices for patients with diseases such…
Manufacturing Is Underway and Anticipated to Significantly Boost Development Efforts LAS VEGAS, NV– Cell MedX Corp. (OTCQB: CMXC) (“Cell MedX” or the “Company”), a development stage company focused on the commercialization of therapeutic devices for patients with diseases such as…
Company Views JAMA Study as Impetus for Novel Diabetes Treatment Options LAS VEGAS, NV–Cell MedX Corp. (OTCQB: CMXC) (“Cell MedX” or the “Company”) a development stage company focused on the discovery, development and commercialization of therapeutic devices for patients with…
HENDERSON, NV–Cell MedX Corp. (OTCQB: CMXC) (“Cell MedX” or the “Company”), a development stage company focused on the discovery, development and commercialization of therapeutic devices for patients with diabetes, announced that its Board of Directors has approved the grant of…
— Company looks for input from leading medical device design firm Las Vegas, Nevada, August 4, 2015, Cell MedX Corp. (OTCQB: CMXC) (“Cell MedX” or the “Company”) a development stage company focused on the discovery, development and commercialization of therapeutic…
LAS VEGAS, NV–Cell MedX Corp. (OTCQB: CMXC) (“Cell MedX” or the “Company”) an early development stage company focused on the discovery, development and commercialization of therapeutic devices for patients with diseases such as diabetes is pleased to update the timeline…